Healthcare Global Enterprises Ltd is one of India's leading oncology treatment specialists with presence across the country. HCG revenues in Q4FY21 grew by 10.6% YoY to Rs.298 cr during the quarter with good momentum across existing centres inspite of decline in international patients. Consolidated operating EBITDA was Rs. 34.9 cr, reporting a growth of 11.6% YoY, amidst COVID-led disruptions in the quarter. Milann Fertility Centre delivered positive growth on QoQ basis across...